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ω-conopeptideN-type calcium channels play an important role in synaptic transmission and a drug that blocks these channels
has become an important tool in controlling chronic pain. The development of new N-channel-targeted drugs
is dependent on a better understanding of the gating of these channels and how that gating can be modulated.
We have previously concluded that ω-conotoxin GVIA (GVIA) is a gating modiﬁer that acts by destabilizing the
N-channel open state. However, this conclusion was largely based on our modeling results and requires
experimental support. Roscovitine, a tri-substituted purine, has been shown to stabilize theN-channel open state
to slow gating charge relaxation, which provides a direct test of our hypothesis for GVIA-induced gating
modiﬁcation.We found that roscovitine couldmodulate gating current in thepresence ofGVIA,which shows that
roscovitine can still affect the gating of the GVIA-bound N-channel. However, the magnitude of the roscovitine-
induced slowing of Off-gating current was signiﬁcantly reduced. In addition to conﬁrming our hypothesis, our
evidence supports an additional effect of GVIA to alter gating transitions between N-channel closed states. By
strongly limiting access to the N-channel open state, GVIA analogs that selectively induce this modulation could
provide the basis for the next generation drugs that treat chronic pain.anum and magnesium external
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N-type calcium channels play an important role in the central and
peripheral nervous systems by controlling neurotransmission [1–3].
These channels mediate the neurotransmission of pain signals in the
spinal cord, which makes the N-channel a desirable target for the
treatment of chronic pain [4–7]. There is currently only one drug that
targetsN-type channels [6,8,9], Prialt, thathas been approvedby theFDA
for chronic pain treatment. Prialt is a synthetic version of ω-conotoxin
MVIIA that has proven to be extremely effective from treating some
patients, but others have experienced serious side effects including
dizziness, confusion and death [6–10]. Thus, it is important to ﬁnd
additional N-channel blockers that can expand the number of patients
beneﬁting from this type of treatment.Prialt and related peptides such as ω-conotoxin GVIA (GVIA) are
thought to block N-type channels by plugging the pore [11–14], but we
recently demonstrated that GVIA could also modify N-channel gating
[15]. We demonstrated that GVIA accelerated N-channel gating charge
movement and our theoretical simulations showed that gating modi-
ﬁcation alone (no pore block) would reduce action potential-induced
Ca2+ inﬂux via N-channels by ∼50% [15]. Our modeling also led us to
conclude that GVIA modulates N-channel gating by destabilizing the
open state [15]. However, it is critical to support this conclusion with
experimental data, which is difﬁcult because of the complete pore block
induced by this toxin.
Roscovitine is a tri-substituted purine that slows N-channel closing
by stabilizing the open state [16–19]. One result of this stabilization is
that Off-gating charge movement is slowed so that it appears that the
gating charge cannot move until the channel begins to close [20]. The
discovery of roscovitine-slowed Off-gating charge movement pro-
vides uswith the experimental opportunity to test our hypothesis that
GVIA affects gating by destabilizing the open state.
Based on our previous work, we predicted that the GVIA-
destabilization of the open state would profoundly reduce the effect
of roscovitine on Off-gating current, and our experimental results fully
support this prediction. Our conclusion that GVIA destabilizes the N-
channel open state is also supported by new simulations with our
model that has been updated to more accurately reproduce our gating
current data [20]. However, this model supports an additional effect of
GVIA to speed closed–closed transitions. Our modeling shows that
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appears to be an increased relaxation speed of each voltage sensor
involved in channel activation [15].
2. Materials and methods
2.1. HEK cell transfection
We utilized the calcium phosphate precipitation method to
transfect HEK293 cells with α1B-CFP (CaV2.2), α2δ, and β2a subunits
as described previously [21]. α1B-CFP (GenBank™ number AF055477)
contained CFP encoding cDNA attached to N-terminus of α1B, which
was used to ﬂuorescently identify transfected cells. HEK293 cells were
maintained in standard DMEM/Glutamax® medium containing 10%
fetal bovine serum and 1% antibiotic–antimycotic at 37 °C in 5% CO2
incubator. We speciﬁcally chose the CaVβ2a subunit to limit the
inhibition induced by roscovitine [20]. We recently demonstrated that
this inhibition results from roscovitine driving N-channels into
closed-state inactivation [17], and occupancy of this state is abrogated
by co-expression of the β2a subunit [20], which allows us to study the
roscovitine-induced slowed N-channel closing in isolation from the
other effect.
2.2. Measurement of gating currents
Cells were voltage-clamped using thewhole-cell conﬁguration of the
patch clamp technique. Pipettes were pulled from Schott 8250 glass
(Garner Glass, Claremont, CA) on a Sutter P-97 puller (Sutter Instru-
ments Co., Novato, CA). Currentswere recorded using anAxopatch 200A
ampliﬁer (Molecular Devices, Sunnyvale, CA) and digitized with ITC-18
data acquisition interface (Instrutech Corporation, Port Washington,
NY). Experiments were controlled by a Power Macintosh G3 computer
(Apple Computer, Cupertino, CA) running S5 data acquisition software
written by Dr. Stephen Ikeda (NIH, NIAAA, Bethesda, MD). Leak current
was subtracted online using a −P/8 protocol as previously described
[15]. All recordings were carried out at room temperature and the
holding potential was −120 mV. Gating currents were digitized at
50 kHz after analog ﬁltering at 10 kHz using 40%–60% series resistance
compensation leaving a maximum voltage-clamp error of b5 mV. There
was no correlation between gating current parameters and maximum
voltage error and/or series resistance [15].
As previously described [15], we isolated gating currents by using a
lanthanum and magnesium (LaMg) external solution containing (in
mM): 0.2 LaCl3, 5 MgCl2, 0.1 N-methyl-D-glucamine (NMG)-EGTA,
145 NMG-Cl, 10 NMG-HEPES with osmolarity=325 mOsm and
pH=7.4. In LaMg, the free [La3+] was 0.1 mM since 1/2 the La3+
was chelated by 0.1 mM EGTA [22–24]. We added 5 µM GVIA to this
solution to make LaMg-GVIA. R-roscovitine (roscovitine) was pre-
pared as a 50 mM stock solution in DMSO and stored at −30 °C. The
50 mM stock was diluted into the LaMg and LaMg-GVIA solutions to
make a ﬁnal concentration of 100 µM roscovitine. DMSOwas added to
the control solutions so that the DMSO concentration (0.2%) was
identical in all external solutions. Test solutions were applied from a
gravity-fed perfusion system with an exchange time of 1–2 s.
2.3. Data analysis
Data were analyzed using IgorPro (WaveMetrics, Lake Oswego,
OR) running on a Macintosh computer. Gating currents were ﬁltered
using an IgorPro binomial smooth function, which is a Gaussian ﬁlter
with a 2.3 kHz cutoff. This ﬁltering did not noticeably change the
gating current waveform but greatly improved the signal-to-noise
ratio. Small steady state currents introduced by the −P/8 leak
subtraction protocol weremeasured at the end of the voltage step and
subtracted from gating currents [15]. The charge (Q) moved by
depolarization or repolarization (QOn or QOff, respectively) was cal-culated by integrating gating currents over the entire voltage step. The
Q vs. voltage (V) curve was ﬁtted by a single Boltzmann function to
yield the half maximal voltage (V0.5), slope factor (k), andmaximumQ
(Qmax). The On- (τQOn) and Off- (τQOff) gating current time constants
(τs) were determined by ﬁtting gating current with a single
exponential equation [15]. We have previously utilized double
exponential ﬁtting of ionic current to examine the effect of roscovitine
and its analogs on tail currents [17,18]. However, these papers
investigated sub-maximal effects of these drugs so that the channels
existed in both the roscovitine-bound and unbound states. Here we
are using a near maximal roscovitine concentration (100 µM) so that
nearly all activated channels will be in the roscovitine-bound state
[17], which is the reason single exponential ﬁtting of roscovitine-
slowed Off-gating current provided excellent correspondence (see
Fig. 1). Group data were calculated as mean±SD throughout the
paper. Paired T-test was used for within-cell comparisons. One-way
ANOVA with the Newman–Keuls posthoc test was used to test for
differences among three or more independent groups.
2.4. Computer simulations
Simulated currents were generated using Axovacs 3 (written by
Stephen W. Jones, Case Western Reserve University) on a Macintosh
G4 computer running Virtual PC 6 (Microsoft, Inc, Seattle, WA).
Voltage-dependent rate constants (kx) in the model were calculated
from:
kx = Ax exp VzxF = RTð Þ
where Ax is the rate constant at 0 mV, zx is the charge moved, and R, T,
F are the gas constant, absolute temperature and Faraday's constant,
respectively (see Table 1 for Ax and zx values). Simulated currents
were analyzed using IgorPro.
2.5. Chemicals
All experiments utilized R-roscovitine from LC Labs (Woburn, MA)
and GVIA from Bachem, Inc. (King of Prussia, PA). Cell culture
materials were from Invitrogen (Carlsbad, CA). Other chemicals were
obtained from Sigma (St. Louis, MO).
3. Results
We used roscovitine to probe N-channel gating currents in control
and in the presence of GVIA to test our hypothesis that GVIA
destabilizes the N-channel open state. Roscovitine slows Off-gating
current [20] and we predicted that this effect would be signiﬁcantly
reduced by GVIA. All gating currents were recorded in lanthanum and
magnesium (LaMg)±5 µM GVIA. This GVIA concentration was
chosen to obtain a block of N-type channels that was sufﬁciently
rapid to allow within-cell comparisons that would make the effect of
GVIA and roscovitine much easier to interpret [15]. This concentration
is speciﬁc for N-type channels since we found no effect of 5 µM GVIA
on gating currents generated by L-type channels (CaV1.2) (n=4, not
shown). The effect of roscovitine is illustrated in Fig. 1A. As we
recently demonstrated [20], the On-gating current observed at the
beginning of the voltage step shows little if any effect in response to
100 µM roscovitine, while the Off-gating current is dramatically
slowed and peak current is reduced (Fig. 1A, C), as expected for a ﬁxed
amount of charge moving over a longer time. In the presence of GVIA,
the On-gating current is not affected at this voltage as we previously
demonstrated [15], but Off-gating current is signiﬁcantly accelerated
(Fig. 1B, C).While roscovitine can signiﬁcantly slowOff-gating current
in the presence of GVIA, the change in τQOff is signiﬁcantly reduced
compared to that in LaMg (Fig. 1C, D). The ability of roscovitine to
affect gating implies that GVIA does not prevent roscovitine binding to
Fig. 1. Roscovitine-induced change in Off-gating current is decreased by GVIA. (A) Gating
currents are shown in the absence of GVIA (LaMg) to illustrate the effect of 100 µM
roscovitine (Rosc, black trace). Note the smaller peakOff-gating current and slower gating
current relaxation at−50 mV. (B) The addition of GVIA to LaMg (+GVIA) accelerates Off-
gating currents in the absence of roscovitine, and also has a dramatic impact in the
presence of 100 µM roscovitine (Rosc, black trace). (C) Single exponential ﬁttingwas used
to determine τQOff at−50 mV following voltage steps to +80mV (see smooth gray lines
superimposed on the Off-gating currents in panels A and B). Mean τQOff±SD is shown for
Off-gating currents measured in LaMg and after the addition of 5 µM GVIA (+GVIA). For
eachbar “C” indicates control (i.e. no roscovitine) and “R” indicates thepresenceof 100 µM
roscovitine. Data from ﬁve cells were averaged (within-cell comparisons for all
treatments) and the small letters above each bar indicate signiﬁcant differences
(pb0.05, ANOVA, Newman–Keuls posthoc analysis). (D) The percentage increase in
τQOff induced by100 µMroscovitine is plotted fromthe data shown inpanel C. The asterisk
indicates that the change is signiﬁcantly different from zero and the horizontal bracket
indicates that the roscovitine-induced change is signiﬁcantly different between LaMg and
GVIA (pb0.05, ANOVA, Newman–Keuls posthoc analysis).
Table 1
Rate parameters for N-channel model.
Transition Cntl`
A
GVIA1
A
GVIA2
A
Transition
z
1→2 800 1→2 1
2→1 200 400 2→1 –1
2→3 2200 2→3 1
3→2 800 1200 3→2 –1
3→4 2500 3→4 1
4→3 2000 3000 4→3 –1
4→5 3000 4→5 –
5→4 5000 5→4 –
5→6 1800 900 900 5→6 0.8
6→5 2000 4000 4000 6→5 −0.8
6→7 1100 800 800 6→7 0.6
7→6 900 2700 2700 7→6 −0.6
6→8 4[R] 6→8 –
8→6 2000 8→6 –
7→9 4[R] 7→9 –
9→7 150 9→7 –
8→9 1000 4000 4000 8→9 0.6
9→8 61 1020 1020 9→8 −0.6
A (s−1) is the rate constant at 0 mV and z is the chargemoved. See Subsection 2.4 for the
equation used to calculate the rate constant for each voltage. [R] is the roscovitine
concentration (µM). The units of ‘A’ for k68 and k79 are µM−1 s−1. – indicates voltage-
independent rate constants (i.e. no charge moved).
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destabilizes the N-channel open state.
Roscovitine induced a left-shift in the voltage-dependence of N-
channel activation as determined by Boltzmann equation ﬁts (V0.5) to
the ionic current activation vs. voltage (V) relationship (∼−10 mV)
and this shift was also observed in the gating charge (Q) vs. V rela-
tionship, but to a smaller degree (∼−4 mV) [20]. In the presence of
GVIA, roscovitine induced a small, but signiﬁcant (pb0.05, T-test),
left-shifted in the QOn–V and QOff–V relationships (Fig. 2). The
roscovitine-induced shift in V0.5 (ΔV0.5) was not signiﬁcantly different
when compared between LaMg and LaMg+GVIA (Fig. 2C, D, E). TheBoltzmann slope factor was not signiﬁcantly altered by roscovitine
in LaMg±GVIA (Fig. 2C, D, F) [20]. The absence of a GVIA-induced
change in the roscovitine effect on V0.5 further supports our con-
clusion that GVIA does not prevent roscovitine binding to the N-type
channels.
Previously we established that channel opening was required to
observe roscovitine-induced slow deactivation [16,18]. Consistent
with this idea, we found that the roscovitine effect onQOff kinetics was
strongly voltage-dependent as expected from open state-dependent
roscovitine binding (Figs. 2A, 3) [20]. Qualitatively, GVIA appeared to
shift the roscovitine effect on QOff to more depolarized voltages (cf.
Fig. 2A and B), which is expected from the ∼10 mV right-shift in the
Q–V relationship induced by the toxin (Fig. 2C, D) [15]. The effect of
GVIA on the voltage-dependence of roscovitine-slowed QOff was
quantiﬁed by determining τQOff from single exponential ﬁtting of the
Off-gating current generated from the Q–V protocol and calculating
the roscovitine-induced change in τQOff (ΔτQOff) in GVIA. The data in
LaMg were previously published [20] so we are showing a single
exponential ﬁt to those data here (Fig. 3A). A plot of ΔτQOff vs. step
voltage (Fig. 3A) showed the dramatic suppression of roscovitine-
induced slowing of QOff illustrated in Figs. 1 and 2. However, the GVIA-
induced suppression of the roscovitine effect on τQOff made it difﬁcult
to quantify the degree to which GVIA shifted the voltage-dependence
of the roscovitine effect. From Fig. 2B it seemed that the roscovitine-
reduction of peak Off-gating current would be a more sensitive
measure of this effect. The magnitude of peak Off-gating current (ICntl
and IRosc in control and roscovitine, respectively) was determined
from the single exponential ﬁtting of Off-gating currents used to
determine τQOff (Fig. 3A). The ratio of peak Off-gating current in
roscovitine vs. control (IRosc/ICntl) nicely illustrates the impact of GVIA
on the voltage-dependence of the roscovitine effect on Off-gating
current (Fig 3B). The IRosc/ICntl ratio was plotted vs. step voltage and ﬁt
using a single Boltzmann equation (Fig. 3B), which yielded a V0.5 in
GVIA that was 32 mV more depolarized than that measured in LaMg
[20]. The V0.5 for the IRosc/ICntl ratio in LaMg (no GVIA) was −18 mV
(slope factor=e-fold for −9 mV), which was depolarized to V0.5=
14 mV (slope factor=e-fold for −7 mV) by the addition of 5 µM
GVIA. This shift is even larger than the GVIA-induced depolarizing
shift in the Q–V relationship (∼10 mV) [15] and further supports the
strong effect of GVIA to disrupt the N-channel open state.
To this point we have used only a narrow voltage range (−50 and
−60 mV) to examine theeffectofGVIAon roscovitine-slowedOff-gating
Fig. 2. Roscovitine left-shifts the Q–V relationship in GVIA. (A) Gating currents without GVIA (LaMg) were activated by the indicted voltage step and recorded with (black traces) and
without (gray traces) 100 µM roscovitine. (B) Gating currents recorded in LaMg+GVIA (+GVIA) with andwithout roscovitine (as indicated for panel A). (C) Typical QOn–V relationships
fromthe same cell forOn-gating current in LaMgand LaMg+5 µMGVIA (+GVIA)with (Rosc, black symbols) andwithout (Cntl, gray symbols) 100 µMroscovitine. The smooth curves are
Boltzmann equation ﬁts to the QOn–V relationships with V0.5=−11.7 mV, slope factor=8.3 for LaMg and V0.5=−16.1 mV, slope factor=9.1 for LaMg in roscovitine, and V0.5=2.5 mV,
slope factor=13.0 for LaMg+GVIAandV0.5=−2.9 mV, slope factor=13.6 for LaMg+GVIA in roscovitine.QOnwasnormalized (norm) to theQmax valueobtained fromBoltzmannﬁtting.
(D)QOff–V relationships are presented as described for panel C. The smooth curves are Boltzmann equation ﬁts to theQOff–V relationshipswith V0.5=−7.4 mV, slope factor=9.3 for LaMg
and V0.5=−13.8 mV, slope factor=9.0 for LaMg in roscovitine, and V0.5=1.2 mV, slope factor=11.1 for LaMg+GVIA and V0.5=−4.4 mV, slope factor=11.7 for LaMg+GVIA in
roscovitine. (E) The average roscovitine-induced shift in V0.5 (ΔV0.5)±SD is shown for both QOn and QOff in LaMg (Gray bars) and LaMg+GVIA (open bars). The data are from the same
4 cells and the shift induced by roscovitine in LaMg is not signiﬁcantly different from that in LaMg+GVIA (ANOVA, Newman–Keuls posthoc analysis). (F) The average roscovitine-induced
shift in Boltzmann slope factor (Δk)±SD is shown as described for panel D. There are no signiﬁcant differences among these data (ANOVA, Newman–Keuls posthoc analysis).
Scheme 1.
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slowsOff-gating current at all voltages and this has provided critical data
for model development [20]. The voltage-dependence of τQOff was
determined over a range of “tail” voltages (−10 to−140 mV) following
a 10-ms step to +60 mV (Fig. 4A). Data from LaMg were published
previously and are depicted here (Fig. 4B) as smooth lines representing
single exponential ﬁts to the τQOff vs. voltage relationship [20]. These
single exponential ﬁts generate a constant (Ve) representing the
voltage-dependence of τQOff, which is plotted in Fig. 4C for all conditions
considered here. Under control conditions (no roscovitine), GVIA
signiﬁcantly reduces τQOff at voltages ranging from −10 to −70 mV,
which results from a 20 mV shift in the τQOff vs. V relationship [20]. At
voltages hyperpolarized to −70 mV, τQOff appears to reach a voltage-
independent plateau that motivated us to introduce a voltage-
independent gating transition in our recent N-channel model update
[20]. In roscovitine, GVIAhasaprofoundeffect onOff-gating currentover
the entire voltage range to signiﬁcantly reduce τQOff relative to that in
LaMg (pb0.05, T-test) (Fig. 4B). The τQOff Ve in roscovitine was
signiﬁcantly reduced by GVIA so that therewas no longer any difference
with control (GVIA alone), unlike the effect of roscovitine in LaMg
(Fig. 4C).3.1. Markov model
In our previous study we were able to qualitatively reproduce the
effect of GVIA on N-channel gating by adjusting only rate constants
associated with the open state [15]. That model was based solely on
whole-cell data, and the qualitative agreement with the experimental
data was satisfactory for our initial description of the GVIA effect.
However, our further investigation of gating currents required a
model that provided better agreement with the experimental results,
which motivated us to generate the model shown in Scheme 1 [20].
Fig. 3. Stronger depolarization is required for roscovitine to affect Off-gating current in
GVIA. (A) ΔτQOff was calculated as the difference in τQOff measured±roscovitine in GVIA
(black squares, n=4). The smooth line is a ﬁt to ΔτQOff in LaMg (±roscovitine, no GVIA)
from Yarotskyy and Elmslie [20]. τQOff was measured at−60 mV following voltage steps
ranging from −120 to +80mV (same protocol used to the generate Q–V relationships
shown in Fig. 2) and ΔτQOff is plotted vs. step voltage. (B) Peak Off-gating current was
measured at −60 mV following voltage steps ranging from −120 to +80mV (same
protocol used for data of panel A)without (ICntl, average of control andwashout data) and
with 100 µMroscovitine (IRosc). The IRosc/ICntl ratio (black squares,n=4) is plotted vs. step
voltage and the smooth line is fromaBoltzmann equationﬁtwithV0.5=14.1 mVand slope
factor e-fold for 7.3 mV. The smooth gray line is from a Boltzmann equation ﬁt to IRosc/ICntl
data in LaMg (no GVIA) that was previously published [20] with V0.5=−18.0 mV and
slope factor=e-fold for 9.1 mV.
Fig. 4. GVIA reduces the roscovitine effect on Off-gating current at all voltages. (A) Typical
gating currents recorded in LaMg+GVIA (+GVIA) with (Rosc, black) and without (Cntl
and WO, gray) 100 µM roscovitine at tail voltages of−40 mV and−120 mV following a
10-ms 60 mV step. The smooth lines superimposed on the Off-gating currents are single
exponential ﬁts to determine τQOff. (B) τQOff was calculated as described under panel A in
LaMg+GVIA (+GVIA) and is plotted against tail voltage for control (Cntl, open circles),
100 µM roscovitine (Rosc, black squares), andwashout (WO, open triangles). The τQOff vs.
voltage relationships were ﬁt (smooth black lines) using a single exponential function to
determine the e-fold change with voltage (Ve) for each condition. The smooth gray and
dashed lines represent the single exponentialﬁt to the τQOff–V relationship obtained in the
absence of GVIAwithout (LaMg) and with (Rosc) 100 µM roscovitine from Yarotskyy and
Elmslie [20]. (C) ThemeanVe±SD is shown for LaMg (n=11) and LaMg+GVIA (+GVIA,
n=5)without (Cntl) andwith (Rosc) 100 µMroscovitine. The small letters aboveeachbar
indicates signiﬁcant differences (pb0.05, ANOVA, Newman–Keuls posthoc analysis).
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experimental gating current results for both control and 100 µM
roscovitine [20]. The essential differences from our earlier model were
the addition of two closed states along the pathway to channel
opening and making the transition rates between C4 and C5 voltage-
independent (indicated by the asterisks in Scheme 1). The reasons for
introducing this transition and its placement are discussed in
Yarotskyy and Elmslie [20]. As a ﬁrst step, we needed to determine
if our previous conclusion that GVIA only alters open state rate
constants was valid for this newmodel. Wemade changes to the open
state rate constants (k56, k65, k67, k76, Table 1 model GVIA1) that were
similar to the adjustments made in our previous model [15], and with
these changes we were able to achieve good agreement with the
effect of GVIA on the Q–V and the τQOff–V relationships (Fig. 5A, B).
However, the simulated τQOn data from this model were not affected
by GVIA as strongly as our experimental results (Fig. 5C). On the other
hand, additional simulations with the GVIA1 model using roscovitine
demonstrated good agreement with our experimental data (Fig. 6D,
open gray circles), so these model parameters were retained for the
next model (GVIA2) in which we made additional adjustments to
address the differencewith the τQOn data. Since rather drastic changes
to the open state rate constants had little effect on τQOn, we focused
on closed-state transitions. From this process, we found good
agreement with our experimental results if the toxin also increased
the backward rate constants between voltage-dependent closed
states (k21, k32, k43, Table 1 model GVIA2). The results from this
model simulation are presented in Fig. 6. We obtained good
agreement with the experimental Q–V relationship both with and
without roscovitine. Indeed, our correspondence was better near the
foot of the Q–V curve in GVIA than with the open state only model
(GVIA1) (cf. Figs. 5A and 6A). The voltage-dependence of τQOff is
nicely reproduced by the GVIA2 model with a strong reduction of the
roscovitine effect by GVIA (Fig. 6B). This new model also addressed
the problem with τQOn since GVIA has a strong effect at voltagesb20 mV, but minimal effect at more depolarized voltage as we
observed in our experimental results (Fig. 6C). One key observation is
the effect of GVIA on the voltage-dependent effect of roscovitine on
Off-gating current. Model simulations show a strong right-shift in this
voltage-dependent effect by GVIA with V0.5 shifting +29 mV
(Fig. 6D), which is close to the +32 mV shift measured from our
experimental data. Our simulations also demonstrated that, consis-
tent with our original prediction, the disruption of the roscovitine
effect by GVIA is mediated by the effect of the toxin on the N-channel
Fig. 5. A model in which GVIA only affects open state transitions cannot account for
changes in On-gating current. For all panels, the symbols represent results from model
simulations and the lines represent experimental data. The gray lines and symbols are
results without GVIA (LaMg, see legend within panel A), and the black lines and symbols
are resultswithGVIA (+GVIA). (A) TheGVIA-induced right-shift of theQ–V relationship is
mimicked by the open state only model (GVIA1, see Table 1 for model parameters) for
depolarized voltages (N0 mV). The simulations were done from a holding potential of
−100 mV and 15-ms voltage steps to the indicated voltage. (B) The model nicely
reproduces the effect of GVIA on τQOff. Simulated gating currents were activated by 10-ms
steps to 60 mV followed by 14-ms steps to the indicated voltage where τQOff was
measured. (C) τQOn was calculated using single exponential ﬁts to the declining phase of
theOn-gating current from the sameprotocol used to generate theQ–V data (see panel A).
τQOn is plotted vs. step voltage. Themodel fails to reproduce the reduction in τQOn induced
by GVIA.
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for both models (cf. Fig. 6D, superimposed open gray circles (GVIA1)
and black squares (GVIA2)). Thus, our experimental and simulation
results fully support our hypothesis that GVIA disrupts the N-channel
open state.
4. Discussion
GVIA is assumed to block N-type calcium current by plugging the
pore [11–14], but we recently found that this toxin can also modulate
N-channel gating currents [15]. Roscovitine slows N-channel closing
by stabilizing the open state [16–19], which also slows gating current
relaxation [20]. These results led us to hypothesize that GVIA would
disrupt the roscovitine-induced slowing of Off-gating current.
Consistent with our prediction, we found that the roscovitine-inducedeffect was signiﬁcantly decreased, and the voltage-dependence of the
roscovitine effect was shifted+32 mV by GVIA, whichwas larger than
the effect of GVIA on the Q–V relationship (+10 mV). This difference
likely reﬂects the profound impact of GVIA to destabilize the open
state, since our modeling showed that additional changes to closed-
state transitions did not affect the GVIA-induced right-shift of the
voltage-dependent roscovitine effect on Off-gating current. However,
the GVIA-induced reduction of τQOn could not be explained by our
model in which we altered only open state-associated transition rates
(GVIA1 model). This effect of GVIA required an additional effect on
closed-state rate constants (GVIA2 model). We conclude that GVIA
can affect both open state and closed-state transition rates, but the
effect on open state rate constants primarily impacts roscovitine-
induced slowed Off-gating current.
4.1. Model of N-channel gating
One of the primary predictions of our original N-channel model
was that the channel would exhibit two open states during normal
gating, and roscovitine would increase themean open time by binding
to the open state [16]. There was single channel evidence for two open
states under normal conditions [25], but there was no single channel
data to support the roscovitine effect. This gap was recently closed
with recordings from tsA201 cells stably expressing N-type channels
showing that roscovitine increased the long open time, but not the
short open time [19]. Thus, the essential features of the open state
binding of roscovitine to slow N-channel closing have support from
whole-cell, gating and single channel current recordings [16,19,20].
Our gating current results motivated us to recently update our N-
channel model to include a voltage-independent transition between
closed states along the pathway to channel opening [20]. The primary
reason was that τQOff reaches a voltage-independent plateau at
voltages b−70 mV, which could not be modeled without introducing
a voltage-independent transition. Unlike L-type channels [26], we did
not associate this transition with the open state since N-channel open
times are voltage-dependent [27,28]. However, single channel
recording did identify a voltage-independent closed state that showed
increased occupancy with depolarization as expected for a state near
the open states [27]. Given this evidence we associated the voltage-
independent rate constants with the closed–closed transition next to
the ﬁrst open state [20]. Besides the addition of closed states, the other
major change with this new model was the general reduction in the
magnitude of the forward rate constants between closed states (cf.
[16,20]). This was required to increase the simulated τQOn to match
that experimentally observed. These changes to the model required
that we re-evaluate our previous conclusion that GVIA only affects the
N-channel open state. We found that changes in the open state rate
constants alone could not reproduce the toxin effect on τQOn, which
was signiﬁcantly reduced in our experimental results [15]. This lack of
correspondence was not surprising since in developing the new
model we had noticed that changes in the open state transitions had a
relative minor effect on τQOn. Thus, additional increases in the
backward rate constants between voltage-dependent closed states
were required to provide good correspondence between our
simulated and experimental results. This information permits us to
expand our original hypothesis to suggest that GVIA alters gating by
affecting N-channel open and closed states. Furthermore, our
modeling suggests that many of these gating changes result from
GVIA increasing the relaxation rate of all voltage sensors involved in
N-channel activation, since all of the voltage-dependent backward
rate constants are increased in our model (GVIA2).
4.2. Mechanism for the GVIA effect
Amino acid mutations within the extracellular loop between
transmembrane segment 5 (S5) and the Pore-loop (P-loop) of domain
Fig. 6. The addition of altered closed-state transitions to the model (GVIA2) reproduces all GVIA effects on N-channel gating. The symbols represent results from model simulations
and the lines represent experimental data. The gray lines and symbols are results without GVIA (LaMg), and the black lines and symbols are results with GVIA. The simulations were
done as described in the Fig. 5 legend. (A) The roscovitine-induced left-shift of the Q–V relationship is mimicked by our model both with and without GVIA. (B) The model nicely
reproduces the effect of GVIA on τQOff in the presence and absence of roscovitine. (C) τQOn is plotted vs. step voltage and the GVIA2 model captures the reduction in τQOn induced by
GVIA and the nearly absent effect of roscovitine on τQOn. (D) The IRosc/ICntl ratio was calculated as described in the Fig. 3 legend and is plotted vs. step voltage. The simulations show
the strong right-shift in the roscovitine effect induced by GVIA. The solid black symbols are simulation results using the GVIA2 model (as with the other panels), but here we also
superimpose simulation results using the GVIA1 model (open gray circles) to demonstrate that the roscovitine effect is mimicked by adjusting only open state rate constants.
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suggests that this region is important for toxin binding. We do not yet
know the location of the roscovitine binding site on the N-channel to
slow deactivation, but it seems clear from our data that toxin
occupancy does not prevent roscovitine binding to the channel. An
alternative possibility was that GVIA slows roscovitine binding so that
we observe only a partial effect with our 10–15-ms voltage steps.
There are several results that lead us to reject this possibility in favor
of one where roscovitine binding is not altered. The ﬁrst is that the
right-shift in the Q–V relationship induced by roscovitine is not
affected by GVIA. The second result is that the IRosc/ICntl ratio shows a
maximal roscovitine effect on peak Off-gating current at step voltages
≥40 mV (Fig. 3B), which suggests that further depolarization or
duration of that depolarization will not increase the roscovitine effect.
Thus, the evidence supports our conclusion that roscovitine can bind
to a GVIA-occupied channel.
Regarding the potentialmechanism bywhich GVIA alters N-channel
gating, we previously presented two possibilities: allosteric modulation
and electrostatic interaction with the voltage sensors [15]. Unfortu-
nately, our data do not provide additional guidance to support ﬁrm
mechanistic conclusions. We can conclude that the GVIA effect is not a
simple surface charge screening effect as can be observed by altering
external divalent cation concentration [29]. Surface charge screening ischaracterized by a shift in all voltage-dependent gating parameters (e.g.
Boltzmann V0.5) without an alteration in the voltage-dependence of
those parameters (e.g. Boltzmann slope factor). A positively charged
peptide derived from the sodium channel blocker μ-conotoxin GIIIA has
been shown to modulate sodium channel gating by a surface charge
screening mechanism [30]. However, GVIA increases the Boltzmann
slope factor to spread chargemovementover awider voltage range than
is observed under control (LaMg) conditions [15]. In addition, the
voltage-dependence of τQOff (Ve) is also reduced byGVIA [15]. Thus, the
voltage-dependence of these gating parameters is altered by GVIA,
which is contrary to predictions from a simple charge screening
mechanism. It will be very interesting to investigate the effect of
GVIA-related toxins (e.g. ω-conotoxin MVIIA and MVIIC), which have a
different number of charged amino acid residues and could provide
valuable insights into themechanism (e.g. allosteric vs. electrostatic) by
which N-channel targeted toxins modulate gating.
4.3. N-channel gating modulation: potential clinical implications
Our ﬁndings support our previous hypothesis that GVIA destabi-
lizes the N-channel open state. Thus, researchers now have drugs
available to either stabilize (roscovitine) or destabilize (GVIA) the
open state, which can be used as probes to uncover critical new
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these drugs may become lead compounds for the development of
clinically effective treatments for diseases that could beneﬁt from
altered N-channel gating. Drugs like roscovitine could be helpful for
treatment of diseases associated with decreased N-channel function.
For example, it has been proposed that roscovitine-like drugs could be
useful in the treatment of Lambert–Eaton myasthenia syndrome that
is associated with a decrease in presynaptic CaV2 channels [31], since
roscovitine enhances action potential-induced calcium inﬂux via
these channels [16,31]. The GVIA-related drug Prialt (ω-conotoxin
MVIIA) is already an important drug for the treatment of chronic pain
[6,7,9,10]. However, some patients react poorly to Prialt, which
supports the need for further research into new N-channel targeted
blockers/gating modulators. The identiﬁcation of novel drugs that
mimic the GVIA effect on gating without blocking the pore could be an
important breakthrough in this process. Much more work is needed,
but the insights already gained from working with these gating
modulators provides strong motivation for additional investigation.
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